Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Revealing the Hidden Impact: Family Spillover E...
By
Thanusha Pillay
July 29, 2024
Introduction Cost-utility analysis (CUA) is increasingly used in healthcare decision-making for funding, reimbursement, and pricing of new interventions. Health Technology Assessment (HTA) agenci...
Transformation of Health Technology Assessment in Türkiye
The Role of Pull Incentives in Addressing Antimicrobial Resistance
The Shift to Value-Based Drug Pricing in the United States
Healthcare Decision-Making with MCDA Framework: The Saudi Arabian Perspective
Health Technology Assessment in South Africa: Towards NHI
Quality-Adjusted Life Year (QALY) in Modern Healthcare Decision-Making
Self-Management of Vaginal Pessaries: A Viable Alternative for Pelvic Organ P...
The Shifting Nature and Impact of Health Technology Assessment
Managing Access to Medicines in the Future: Innovations and Strategies
Insights into Austria’s Pricing and Pharmaceutical Policy
Managed Access of Dostarlimab: For Endometrial Cancer
Enhancing Efficiency of Literature Review in Healthcare Research via GPT-4
« Previous
1
…
4
5
6
7
8
…
12
Next »